Professor Anna David
Anna is Director of the Elizabeth Garrett Anderson Institute for Women’s Health at University College London in London and an Honorary Consultant in Obstetrics and Maternal Fetal Medicine at UCL Hospital. Clinically she specializes in fetal medicine, severe congenital disease, fetal growth restriction and prevention of preterm birth.
Her research team is developing novel prenatal therapies using stem cells and gene therapy. She also works closely with engineers to optimize fetal imaging for prenatal diagnosis. With a large team she coordinated the introduction of fetal surgery for spina bifida to the UK in 2018 and secured NHS England specialist commissioning.